Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a fecal transplant beat a stubborn stomach bug?

NCT ID NCT07704255

Recruiting now Disease control Sponsor: Sichuan Provincial People's Hospital Source: ClinicalTrials.gov ↗

First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time

Summary

This study tests whether transplanting healthy gut bacteria from a donor can help clear a hard-to-treat H. pylori infection. Adults aged 18 to 70 who have failed at least four standard treatments will receive a fecal microbiota transplant through the anus. The goal is to see if this approach can successfully eradicate the bacteria, offering an alternative for those with resistant infections.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
fecal microbiota transplant given through the anus
What this could lead to
If it works, this could offer a new way to treat hard-to-clear H. pylori infections without relying on more antibiotics.
What could go wrong
This is a very small early-phase trial with only 10 participants, so results may not apply widely. The procedure carries risks of infection or other complications from the transplant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HELICOBACTER PYLORI INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Helicobacter pylori infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HELICOBACTER PYLORI INFECTION

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sichuan Provincial People's Hospital

    RECRUITING

    Chengdu, Sichuan, 601172, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.